Delivery Order SPE2DB22D1202-SPE2DB25FVLN2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents with a ceiling value of $1,179.61 under a firm fixed price contract. This competitive award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's headquarters location in...
- The Defense Logistics Agency awarded a $4,712.97 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial with diluents. This contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,966.57 delivery order for Vivitrol 380 mg vial-diluents, with a completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Vivitrol 380 mg vial-diluents, with a ceiling value of $1,062.91. The contract is a firm fixed-price delivery order with an ultimate completion date of April 25, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Vivitrol 380 mg vials with diluents. This is a firm fixed-price delivery order with a ceiling value of $6,007.02 and an ultimate completion date of August 14, 2025. The contract carries no set-aside designation, indicating it was competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,002.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with an ultimate completion date of June 30, 2025. This non-set-aside award was issued on June 27, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $4,004.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $13,236.00 under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 17, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $4,357.27 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of September 17, 2025. This is a firm fixed price contract with no set-aside designation, reflecting competitive procurement practices. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLN2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Vivitrol 380 mg vial diluents, with a contract ceiling value of $4,004.68 and an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the DLA, which enables the company to distribute a broad range of medications and medical supplies to support military and federal healthcare systems globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen regularly fulfills orders for specialty medications, vaccines, and medical devices across multiple therapeutic domains. The Vivitrol product—an extended-release formulation used in opioid use disorder treatment—aligns with the company's established role in supplying specialized pharmaceutical commodities to Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/16/25 |